Search

Search Constraints

You searched for: Author/Creator Monkhorst, Kim

Search Results

11. Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses. (October 2018)

12. Feasibility of Intracoronary GLP-1 Eluting CellBead™ Infusion in Acute Myocardial Infarction. Issue 3 (March 2013)

13. Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice. Issue 2 (3rd August 2022)

14. Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer. Issue 4 (27th October 2020)

15. Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers. Issue 3 (March 2023)

16. Impact of Centralization of Care for Malignant Peritoneal Mesothelioma: A historical cohort study from two Dutch expert centers. Issue 2 (February 2022)

17. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis. (4th November 2021)

18. Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial. Issue 3 (March 2019)

19. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. (10th November 2020)

20. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. (10th November 2020)